Disease activity and damage in juvenile idiopathic arthritis: Methotrexate era versus biologic era

Gabriella Giancane, Valentina Muratore, Valentina Marzetti, Neus Quilis, Belen Serrano Benavente, Francesca Bagnasco, Alessandra Alongi, Adele Civino, Lorenzo Quartulli, Alessandro Consolaro, Angelo Ravelli

Research output: Contribution to journalArticlepeer-review


Objective: To compare the long-term disease state, in terms of activity and damage, of children with juvenile idiopathic arthritis (JIA) who had their disease onset in methotrexate (MTX) or biologic eras. Methods: Patients were included in MTX or biologic era cohort depending on whether their disease presentation occurred before or after January 2000. All patients had disease duration ≥ 5 years and underwent a prospective cross-sectional assessment, which included measurement of disease activity and damage. Inactive disease (ID) and low disease activity (LDA) states were defined according to Wallace, JADAS10, and cJADAS10 criteria. Articular and extraarticular damage was assessed with the Juvenile Arthritis Damage Index (JADI). Results: MTX and biologic era cohorts included 239 and 269 patients, respectively. Patients were divided in the "functional phenotypes" of oligoarthritis and polyarthritis. At cross-sectional visit, patients in the biologic era cohort with either oligoarthritis or polyarthritis had consistently higher frequencies of ID and LDA by all criteria. The measurement of disease damage at cross-sectional visit revealed that the frequency of impairment of > 1 JADI-Articular items was higher in MTX than in biologic era cohort (17.6% versus 11% in oligoarthritis and 52.6% versus 21.8% in polyarthritis). Likewise, frequency of involvement of > 1 JADI-Extraarticular items was higher in the MTX than in the biologic era cohort (26.5% versus 16.2% in oligoarthritis and 31.4% versus 13.5% in polyarthritis). Conclusion: Our study provides evidence of the remarkable outcome improvement obtained with the recent therapeutic advance in JIA.

Original languageEnglish
Article number168
JournalArthritis Research and Therapy
Issue number1
Publication statusPublished - Jul 8 2019


  • Biologic agents
  • Disease activity
  • Disease damage
  • Juvenile idiopathic arthritis
  • Long-term outcome
  • Methotrexate

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Disease activity and damage in juvenile idiopathic arthritis: Methotrexate era versus biologic era'. Together they form a unique fingerprint.

Cite this